Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET Clinical Research Collaboration
Background "Phenotyping asthma with airflow obstruction in middle-aged and older adults"
Asthma with fixed airflow obstruction (AFO) is associated with higher exacerbation rates and mortality compared to non-obstructed asthma, yet its prevalence and clinical profile remain uncertain.
Objetives
We aimed to determine the prevalence, characteristics, and comorbidities of asthma with airflow obstruction in adults ≥50 years.
Methods
Participants with spirometry data from 9 CADSET cohorts (n=69,789) were cross-sectionally analyzed. In 2 asthma- and 4 COPD cohorts, AFO was defined as ever diagnosed asthma with post-BD FEV1/FVC<0.7. In 3 population cohorts, AFO was defined as ever asthma with pre-BD FEV1/FVC<0.7. The prevalence and co-morbidities of AFO were meta-analyzed and characteristics were compared to asthma without airflow obstruction (asthma-only) and COPD without asthma history (COPD-only).
Results
The prevalence of AFO was 2.2% (95%CI: 1.8-2.6%) in the general population, 21.0% (18.5-23.8%) in asthma cohorts and 9.9% (5.0-18.7%) in COPD cohorts. AFO patients reported significantly more dyspnea than asthma- and COPD-only. Compared to asthma-only, AFO were older, more often male, current smokers, had lower BMI, and had higher white blood cell counts, yet showed no significant difference in co-morbidities. Compared to COPD-only, AFO were younger, more often female, never smokers, had higher BMI and had more often depression (24.5 vs 11.5%, p=0.01), osteoporosis (21.8 vs 13.4%, p<0.01), and gastro-esophageal reflux disease (GERD; 36.6 vs 24.7%, p<0.01).
Conclusion
AFO is a prevalent respiratory phenotype associated with more dyspnea than asthma- and COPD-only. AFO patients had more depression, osteoporosis, and GERD compared to COPD-only.
Authors
Xander Bertels, Ahmed Edris, Judith Garcia-Aymerich, Rosa Faner, Howraman Meteran, Torben Sigsgaard, Peter Alter, Claus Vogelmeier, Núria Olvera, Nazanin Zounemat-Kermani, Alvar Agusti, Gavin Donaldson, Jadwiga Wedzicha, Guy Brusselle, Helena Backman, Eva Rönmark, Anne Lindberg, Judith Vonk, Kian Fan Chung, Ian Adcock, Maarten Van Den Berge, Lies Lahousse
Read more
Noticias relacionadas
Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)
Analysis of the global challenges of COPD and asthma and the shared vision of GOLD and GINA to improve diagnosis, access to inhaled therapies and patient outcomes worldwide.
Climate change and respiratory health: implications for respiratory clinicians in primary and specialist care
Review on climate change and respiratory health, focusing on chronic respiratory diseases and implications for primary and specialist care.
Treatable Traits. Why, What, How?
Discover how the Treatable Traits approach transforms the management of asthma, bronchiectasis, and COPD through personalized precision medicine strategies.
COPD Management in Primary Care: Underutilisation of Nursing Consultations
Analysis of COPD management in primary care highlighting the role and underutilisation of nursing consultations and healthcare utilisation patterns in real-world patients.
Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPD
Joint GOLD/GLI statement on spirometry to define airflow obstruction and confirm COPD diagnosis, aiming to harmonize criteria and improve global practice.
Video del evento: Transformando la EPOC, claves para un manejo proactivo
Conferencia sobre el manejo proactivo de la EPOC centrada en el infradiagnóstico, el control clínico y el seguimiento estructurado del paciente.
Artículos
Asthma
- 759578·Alberto Papi et Al.-Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
- 759785·Richard Beasley et Al – Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
- 768973·James Fingleton, Rob Mclachlan, Jenny Sparks, Richard Beasley, Alvar Agusti, Peter G Gibson, Ian Pavord, Jo Hardy, Mark Weatherall, Allie Eathorne, Vanessa Mcdonal -Treatable trait guided asthma management: biomarker changes and responder analysis
- 768973·Xander Bertels et Al.- Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET Clinical Research Collaboration
- 769799·Alvar Agusti, Peter G. Gibson, Vanessa M. McDonald. Treatable Traits in Airway Disease: From Theory to Practice
Estudios
- 759397·Alberto Sandiumenge et Al.-Systemic Inflammation Differences in Brain-vs. Circulatory-Dead Donors: Impact on Lung Transplant Recipients
- 759578·Alberto Papi et Al.-Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
- 759689·Kilian Vellvé et Alt.- Pulmonary vascular reactivity in growth restricted fetuses using computational modelling and machine learning analysis of fetal Doppler waveforms.
- 769273· Singh D, Criner GJ, Agustí A et al. Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
- 769685·Nuria Olvera et Al.- Lung Tissue Multi-Layer Network Analysis Uncovers the Molecular Heterogeneity of COPD
Imagen obtenida en Canva Pro.